Preclinical and clinical evaluation of interleukin 3.
Ganser
A
A
Department of Haematology, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.
Ottmann
O G
OG
Seipelt
G
G
Hess
U
U
Geissler
G
G
Merget
R
R
Falk
S
S
Maurer
A
A
Eder
M
M
Hoelzer
D
D
D000740:Anemia / Q000628:therapy*; D000818:Animals; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000187:drug effects; D006801:Humans; D007377:Interleukin-3 / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity
D007377:Interleukin-3; D011994:Recombinant Proteins